Download PDF
Clin Colon Rectal Surg 2022; 35(06): 475-486
DOI: 10.1055/s-0042-1758139
Review Article

Crohn's of the Pouch: Now What?

Tara M. Connelly
1   Department of Colorectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio
,
Eddy Lincango
1   Department of Colorectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio
,
Stefan D. Holubar
1   Department of Colorectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio
› Author Affiliations Funding Crohn's and Colitis Foundation, American Society of Colon & Rectal Surgeons. All other authors have no financial disclosures.
› Further Information
    Permissions and Reprints

Abstract

Total proctocolectomy and ileal pouch anal anastomosis (IPAA) is the gold standard surgical treatment for the majority (∼90%) of ulcerative colitis (UC) patients. In cases of carefully selected Crohn's colitis patients without small bowel or perianal involvement an “intentional IPAA” may be a viable option for disease resection and restoration of intestinal continuity. More commonly, Crohn's is incidentally found either in the resection specimen or, more commonly, when inflammatory complications subsequently arise after pouch construction for UC or indeterminate colitis. These incidental Crohn's pouches may be diagnosed early or late period post-IPAA.

Crohn's may manifest within the pouch, in the proximal small bowel, and/or distally in the rectal cuff or anus. Like intestinal Crohn's, Crohn's disease of the pouch may be of an inflammatory, fibrostenosing, or fistulizing phenotype. Treatment depends on the phenotype and includes medical treatment, most commonly in the form of tumor necrosis factor inhibitor medications; however, the newer small molecules offer a potential treatment for these patients. Surgery first entails treating the sequelae of Crohn's and is typically staged. In up to 60% of Crohn's pouches, particularly in fistulizing disease and/or recalcitrant perianal disease, the pouch fails and must be defunctioned or excised. In patients with Crohn's pouches in situ long term, outcomes including quality of life are comparable to patients who underwent IPAA for UC.

Keywords

Crohn's colitis - ileal pouch anal anastomosis - inflammatory bowel disease - pouch revision

Abbreviations

ASCA – anti-Saccharomyces cerevisiae antibodies


CD – Crohn's disease


EIM – extra intestinal manifestation(s)


FDA – Food and Drug Administration


IBD – inflammatory bowel disease


IC – indeterminate colitis


Ig – immunoglobulin


IPAA - ileal pouch-anal anastomosis


IRA – ileorectal anastomosis


JAK – Janus kinase


OR – odds ratio


pANCA – anti-neutrophil cytoplasm antibodies


TNFi – tumor necrosis factor inhibitor


TPC – total proctocolectomy


SNP – single nucleotide polymorphism


UC – ulcerative colitis


Disclosures

S.D.H.: consulting fees: Shionogi, Takeda.




Publication History

Article published online:
08 November 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Holubar S, Hyman N. Continence alterations after ileal pouch-anal anastomosis do not diminish quality of life. Dis Colon Rectum 2003; 46 (11) 1489-1491
    CrossrefPubMedGoogle Scholar
  • 2 Justiniano CF, Bhama AR, Holubar SD. Open J-pouch pearls. Dis Colon Rectum 2022; 65 (07) e743-e744
    CrossrefPubMedGoogle Scholar
  • 3 Lavryk OA, Stocchi L, Hull TL. et al. Factors associated with long-term quality of life after restorative proctocolectomy with ileal pouch anal anastomosis. J Gastrointest Surg 2019; 23 (03) 571-579
    CrossrefPubMedGoogle Scholar
  • 4 Holubar SD, Lightner AL, Poylin V. et al; Prepared on behalf of the Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the surgical management of ulcerative colitis. Dis Colon Rectum 2021; 64 (07) 783-804
    Google Scholar
  • 5 Holder-Murray J, Marsicovetere P, Holubar SD. Minimally invasive surgery for inflammatory bowel disease. Inflamm Bowel Dis 2015; 21 (06) 1443-1458
    PubMedGoogle Scholar
  • 6 Holubar SD, Dozois EJ, Privitera A, Pemberton JH, Cima RR, Larson DW. Minimally invasive colectomy for Crohn's colitis: a single institution experience. Inflamm Bowel Dis 2010; 16 (11) 1940-1946
    CrossrefPubMedGoogle Scholar
  • 7 Holubar SD, Larson DW, Dozois EJ, Pattana-Arun J, Pemberton JH, Cima RR. Minimally invasive subtotal colectomy and ileal pouch-anal anastomosis for fulminant ulcerative colitis: a reasonable approach?. Dis Colon Rectum 2009; 52 (02) 187-192
    CrossrefPubMedGoogle Scholar
  • 8 Holubar SD, Privitera A, Cima RR, Dozois EJ, Pemberton JH, Larson DW. Minimally invasive total proctocolectomy with Brooke ileostomy for ulcerative colitis. Inflamm Bowel Dis 2009; 15 (09) 1337-1342
    CrossrefPubMedGoogle Scholar
  • 9 Lopez NE, Zaghyian K, Fleshner P. Is there a role for ileal pouch anal anastomosis in Crohn's disease?. Clin Colon Rectal Surg 2019; 32 (04) 280-290
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Melton GB, Fazio VW, Kiran RP. et al. Long-term outcomes with ileal pouch-anal anastomosis and Crohn's disease: pouch retention and implications of delayed diagnosis. Ann Surg 2008; 248 (04) 608-616
    CrossrefPubMedGoogle Scholar
  • 11 Lightner AL. Crohn's disease of the pouch: convinced it's truly de novo Crohn's disease?. Dis Colon Rectum 2021; 64 (02) 143-144
    CrossrefPubMedGoogle Scholar
  • 12 Shen B, Fazio VW, Remzi FH. et al. Clinical features and quality of life in patients with different phenotypes of Crohn's disease of the ileal pouch. Dis Colon Rectum 2007; 50 (09) 1450-1459
    CrossrefPubMedGoogle Scholar
  • 13 Haveran LA, Sehgal R, Poritz LS, McKenna KJ, Stewart DB, Koltun WA. Infliximab and/or azathioprine in the treatment of Crohn's disease-like complications after IPAA. Dis Colon Rectum 2011; 54 (01) 15-20
    CrossrefPubMedGoogle Scholar
  • 14 Braveman JM, Schoetz Jr DJ, Marcello PW. et al. The fate of the ileal pouch in patients developing Crohn's disease. Dis Colon Rectum 2004; 47 (10) 1613-1619
    CrossrefPubMedGoogle Scholar
  • 15 Hercun J, Côté-Daigneault J, Lahaie RG, Richard C, Wassef R, Poitras P. Crohn's disease after proctocolectomy and IPAA for ulcerative colitis. Dis Colon Rectum 2021; 64 (02) 217-224
    CrossrefPubMedGoogle Scholar
  • 16 Kayal M, Plietz M, Rizvi A. et al. Inflammatory pouch conditions are common after ileal pouch anal anastomosis in ulcerative colitis patients. Inflamm Bowel Dis 2020; 26 (07) 1079-1086
    CrossrefPubMedGoogle Scholar
  • 17 Odze RD. A contemporary and critical appraisal of ‘indeterminate colitis’. Mod Pathol 2015; 28 (Suppl. 01) S30-S46
    CrossrefPubMedGoogle Scholar
  • 18 Kariv Y, Remzi FH, Strong SA, Hammel JP, Preen M, Fazio VW. Ileal pouch rectal anastomosis: a viable alternative to permanent ileostomy in Crohn's proctocolitis patients. J Am Coll Surg 2009; 208 (03) 390-399
    CrossrefPubMedGoogle Scholar
  • 19 O'Riordan JM, O'Connor BI, Huang H. et al. Long-term outcome of colectomy and ileorectal anastomosis for Crohn's colitis. Dis Colon Rectum 2011; 54 (11) 1347-1354
    CrossrefPubMedGoogle Scholar
  • 20 Connelly TM, Koltun WA. The surgical treatment of inflammatory bowel disease-associated dysplasia. Expert Rev Gastroenterol Hepatol 2013; 7 (04) 307-321 , quiz 322
    CrossrefPubMedGoogle Scholar
  • 21 Mylonakis E, Allan RN, Keighley MR. How does pouch construction for a final diagnosis of Crohn's disease compare with ileoproctostomy for established Crohn's proctocolitis?. Dis Colon Rectum 2001; 44 (08) 1137-1142 , discussion 1142–1143
    CrossrefPubMedGoogle Scholar
  • 22 Angriman I, Pirozzolo G, Bardini R, Cavallin F, Castoro C, Scarpa M. A systematic review of segmental vs subtotal colectomy and subtotal colectomy vs total proctocolectomy for colonic Crohn's disease. Colorectal Dis 2017; 19 (08) e279-e287
    Google Scholar
  • 23 Yamamoto T, Bain IM, Allan RN, Keighley MR. Persistent perineal sinus after proctocolectomy for Crohn's disease. Dis Colon Rectum 1999; 42 (01) 96-101
    CrossrefPubMedGoogle Scholar
  • 24 Dozois RR, Kelly KA, Beart Jr RW, Beahrs OH. Improved results with continent ileostomy. Ann Surg 1980; 192 (03) 319-324
    CrossrefPubMedGoogle Scholar
  • 25 Kock NG. Intra-abdominal “reservoir” in patients with permanent ileostomy. Preliminary observations on a procedure resulting in fecal “continence” in five ileostomy patients. Arch Surg 1969; 99 (02) 223-231
    CrossrefPubMedGoogle Scholar
  • 26 Goligher JC, Lintott D. Experience with 26 reservoir ileostomies. Br J Surg 1975; 62 (11) 893-900
    CrossrefPubMedGoogle Scholar
  • 27 Halvorsen JF, Heimann P, Hoel R, Nygaard K. The continent reservoir ileostomy: review of a collective series of thirty-six patients from three surgical departments. Surgery 1978; 83 (03) 252-258
    PubMedGoogle Scholar
  • 28 Le Q, Melmed G, Dubinsky M. et al. Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's disease. Inflamm Bowel Dis 2013; 19 (01) 30-36
    CrossrefPubMedGoogle Scholar
  • 29 Grobler SP, Hosie KB, Affie E, Thompson H, Keighley MR. Outcome of restorative proctocolectomy when the diagnosis is suggestive of Crohn's disease. Gut 1993; 34 (10) 1384-1388
    CrossrefPubMedGoogle Scholar
  • 30 de Oca J, Vilar L, Castellote J. et al. Immunodulation with tacrolimus (FK506): results of a prospective, open-label, non-controlled trial in patients with inflammatory bowel disease. Rev Esp Enferm Dig 2003; 95 (07) 465-470 , 459–464
    PubMedGoogle Scholar
  • 31 Regimbeau JM, Panis Y, Pocard M. et al. Long-term results of ileal pouch-anal anastomosis for colorectal Crohn's disease. Dis Colon Rectum 2001; 44 (06) 769-778
    CrossrefPubMedGoogle Scholar
  • 32 Shen B, Patel S, Lian L. Natural history of Crohn's disease in patients who underwent intentional restorative proctocolectomy with ileal pouch-anal anastomosis. Aliment Pharmacol Ther 2010; 31 (07) 745-753
    CrossrefPubMedGoogle Scholar
  • 33 Panis Y, Poupard B, Nemeth J, Lavergne A, Hautefeuille P, Valleur P. Ileal pouch/anal anastomosis for Crohn's disease. Lancet 1996; 347 (9005): 854-857
    CrossrefPubMedGoogle Scholar
  • 34 Hyman NH, Fazio VW, Tuckson WB, Lavery IC. Consequences of ileal pouch-anal anastomosis for Crohn's colitis. Dis Colon Rectum 1991; 34 (08) 653-657
    CrossrefPubMedGoogle Scholar
  • 35 Koltun WA, Schoetz Jr DJ, Roberts PL, Murray JJ, Coller JA, Veidenheimer MC. Indeterminate colitis predisposes to perineal complications after ileal pouch-anal anastomosis. Dis Colon Rectum 1991; 34 (10) 857-860
    CrossrefPubMedGoogle Scholar
  • 36 Marcello PW, Schoetz Jr DJ, Roberts PL. et al. Evolutionary changes in the pathologic diagnosis after the ileoanal pouch procedure. Dis Colon Rectum 1997; 40 (03) 263-269
    CrossrefPubMedGoogle Scholar
  • 37 Heimann TM, Swaminathan S, Slater GI, Kurtz RJ. Perianal fistula after ileoanal pouch in patients with ulcerative colitis: a review of 475 patients operated on at a major IBD center. Dis Colon Rectum 2022; 65 (01) 76-82
    CrossrefPubMedGoogle Scholar
  • 38 Lightner AL, Mathis KL, Dozois EJ. et al. Results at up to 30 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Inflamm Bowel Dis 2017; 23 (05) 781-790
    CrossrefPubMedGoogle Scholar
  • 39 Shannon A, Eng K, Kay M. et al. Long-term follow up of ileal pouch anal anastomosis in a large cohort of pediatric and young adult patients with ulcerative colitis. J Pediatr Surg 2016; 51 (07) 1181-1186
    CrossrefPubMedGoogle Scholar
  • 40 Deutsch AA, McLeod RS, Cullen J, Cohen Z. Results of the pelvic-pouch procedure in patients with Crohn's disease. Dis Colon Rectum 1991; 34 (06) 475-477
    CrossrefPubMedGoogle Scholar
  • 41 Kent TH, Ammon RK, DenBesten L. Differentiation of ulcerative colitis and regional enteritis of colon. Arch Pathol 1970; 89 (01) 20-29
    PubMedGoogle Scholar
  • 42 McIntyre PB, Pemberton JH, Wolff BG, Dozois RR, Beart Jr RW. Indeterminate colitis. Long-term outcome in patients after ileal pouch-anal anastomosis. Dis Colon Rectum 1995; 38 (01) 51-54
    CrossrefPubMedGoogle Scholar
  • 43 Hartley JE, Fazio VW, Remzi FH. et al. Analysis of the outcome of ileal pouch-anal anastomosis in patients with Crohn's disease. Dis Colon Rectum 2004; 47 (11) 1808-1815
    CrossrefPubMedGoogle Scholar
  • 44 Brown CJ, Maclean AR, Cohen Z, Macrae HM, O'Connor BI, McLeod RS. Crohn's disease and indeterminate colitis and the ileal pouch-anal anastomosis: outcomes and patterns of failure. Dis Colon Rectum 2005; 48 (08) 1542-1549
    CrossrefPubMedGoogle Scholar
  • 45 Jackson KL, Stocchi L, Duraes L, Rencuzogullari A, Bennett AE, Remzi FH. Long-term outcomes in indeterminate colitis patients undergoing ileal pouch-anal anastomosis: function, quality of life, and complications. J Gastrointest Surg 2017; 21 (01) 56-61
    CrossrefPubMedGoogle Scholar
  • 46 Zaghiyan K, Kamiński JP, Barmparas G, Fleshner P. De novo Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis and inflammatory bowel disease unclassified: long-term follow-up of a prospective inflammatory bowel disease registry. Am Surg 2016; 82 (10) 977-981
    CrossrefPubMedGoogle Scholar
  • 47 Tekkis PP, Fazio VW, Remzi F, Heriot AG, Manilich E, Strong SA. Risk factors associated with ileal pouch-related fistula following restorative proctocolectomy. Br J Surg 2005; 92 (10) 1270-1276
    CrossrefPubMedGoogle Scholar
  • 48 Shen B, Kochhar GS, Rubin DT. et al. Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol 2022; 7 (01) 69-95
    CrossrefPubMedGoogle Scholar
  • 49 Sagar PM, Dozois RR, Wolff BG. Long-term results of ileal pouch-anal anastomosis in patients with Crohn's disease. Dis Colon Rectum 1996; 39 (08) 893-898
    CrossrefPubMedGoogle Scholar
  • 50 Shen B, Remzi FH, Hammel JP. et al. Family history of Crohn's disease is associated with an increased risk for Crohn's disease of the pouch. Inflamm Bowel Dis 2009; 15 (02) 163-170
    CrossrefPubMedGoogle Scholar
  • 51 Tyler AD, Milgrom R, Xu W. et al. Antimicrobial antibodies are associated with a Crohn's disease-like phenotype after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2012; 10 (05) 507-12.e1
    CrossrefPubMedGoogle Scholar
  • 52 Robbins L, Zaghiyan K, Melmed G. et al. Outcomes with anti-tumour necrosis factor-alpha therapy and serology in patients with de novo Crohn's disease after ileal pouch anal anastomosis. J Crohn's Colitis 2017; 11 (01) 77-83
    CrossrefPubMedGoogle Scholar
  • 53 Barnes EL, Kochar B, Jessup HR, Herfarth HH. The incidence and definition of Crohn's disease of the pouch: a systematic review and meta-analysis. Inflamm Bowel Dis 2019; 25 (09) 1474-1480
    CrossrefPubMedGoogle Scholar
  • 54 Holubar SD. Prevention, diagnosis, and treatment of complications of the IPAA for ulcerative colitis. Dis Colon Rectum 2018; 61 (05) 532-536
    CrossrefPubMedGoogle Scholar
  • 55 Gregory M, Weaver KN, Hoversten P. et al. Efficacy of vedolizumab for refractory pouchitis of the ileo-anal pouch: results from a multicenter US cohort. Inflamm Bowel Dis 2019; 25 (09) 1569-1576
    CrossrefPubMedGoogle Scholar
  • 56 Barnes EL, Raffals L, Long MD. et al. Disease and treatment patterns among patients with pouch-related conditions in a cohort of large tertiary care inflammatory bowel disease centers in the United States. Crohns Colitis 360 2020; 2 (03) otaa039
    CrossrefPubMedGoogle Scholar
  • 57 Syal G, Shemtov R, Bonthala N. et al. Pre-pouch ileitis is associated with development of Crohn's disease-like complications and pouch failure. J Crohn's Colitis 2021; 15 (06) 960-968
    CrossrefPubMedGoogle Scholar
  • 58 Sehgal R, Berg A, Hegarty JP. et al. NOD2/CARD15 mutations correlate with severe pouchitis after ileal pouch-anal anastomosis. Dis Colon Rectum 2010; 53 (11) 1487-1494
    CrossrefPubMedGoogle Scholar
  • 59 Sehgal R, Berg A, Polinski JI. et al. Mutations in IRGM are associated with more frequent need for surgery in patients with ileocolonic Crohn's disease. Dis Colon Rectum 2012; 55 (02) 115-121
    CrossrefPubMedGoogle Scholar
  • 60 Melmed GY, Fleshner PR, Bardakcioglu O. et al. Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum 2008; 51 (01) 100-108
    CrossrefPubMedGoogle Scholar
  • 61 Shen B, Fazio VW, Remzi FH. et al. Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis. Clin Gastroenterol Hepatol 2006; 4 (01) 81-89 , quiz 2–3
    CrossrefPubMedGoogle Scholar
  • 62 Holubar SD, Holder-Murray J, Flasar M, Lazarev M. Anti-tumor necrosis factor-α antibody therapy management before and after intestinal surgery for inflammatory bowel disease: a CCFA position paper. Inflamm Bowel Dis 2015; 21 (11) 2658-2672
    CrossrefPubMedGoogle Scholar
  • 63 Colombel JF, Ricart E, Loftus Jr EV. et al. Management of Crohn's disease of the ileoanal pouch with infliximab. Am J Gastroenterol 2003; 98 (10) 2239-2244
    CrossrefPubMedGoogle Scholar
  • 64 Viscido A, Habib FI, Kohn A. et al. Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis. Aliment Pharmacol Ther 2003; 17 (10) 1263-1271
    CrossrefPubMedGoogle Scholar
  • 65 Ferrante M, D'Haens G, Dewit O. et al; Belgian IBD Research Group. Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series. Inflamm Bowel Dis 2010; 16 (02) 243-249
    CrossrefPubMedGoogle Scholar
  • 66 Calabrese C, Gionchetti P, Rizzello F. et al. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis. Aliment Pharmacol Ther 2008; 27 (09) 759-764
    CrossrefPubMedGoogle Scholar
  • 67 Shen B, Remzi FH, Lavery IC. et al. Administration of adalimumab in the treatment of Crohn's disease of the ileal pouch. Aliment Pharmacol Ther 2009; 29 (05) 519-526
    CrossrefPubMedGoogle Scholar
  • 68 Li E, Zhang Y, Tian X. et al. Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome. PLoS One 2019; 14 (02) e0213108
    CrossrefPubMedGoogle Scholar
  • 69 Philpott J, Ashburn J, Shen B. Efficacy of vedolizumab in patients with antibiotic and anti-tumor necrosis alpha refractory pouchitis. Inflamm Bowel Dis 2017; 23 (01) E5-E6
    CrossrefPubMedGoogle Scholar
  • 70 Mir F, Yousef MH, Partyka EK, Tahan V. Successful treatment of chronic refractory pouchitis with vedolizumab. Int J Colorectal Dis 2017; 32 (10) 1517-1518
    CrossrefPubMedGoogle Scholar
  • 71 Coletta M, Paroni M, Caprioli F. Successful treatment with vedolizumab in a patient with chronic refractory pouchitis and primary sclerosing cholangitis. J Crohn's Colitis 2017; 11 (12) 1507-1508
    CrossrefPubMedGoogle Scholar
  • 72 Bethge J, Meffert S, Ellrichmann M, Conrad C, Nikolaus S, Schreiber S. Combination therapy with vedolizumab and etanercept in a patient with pouchitis and spondylarthritis. BMJ Open Gastroenterol 2017; 4 (01) e000127
    CrossrefPubMedGoogle Scholar
  • 73 Bär F, Kühbacher T, Dietrich NA. et al; German IBD Study Group. Vedolizumab in the treatment of chronic, antibiotic-dependent or refractory pouchitis. Aliment Pharmacol Ther 2018; 47 (05) 581-587
    CrossrefPubMedGoogle Scholar
  • 74 Khan F, Gao XH, Singh A, Philpott JR, Shen B. Vedolizumab in the treatment of Crohn's disease of the pouch. Gastroenterol Rep (Oxf) 2018; 6 (03) 184-188
    CrossrefPubMedGoogle Scholar
  • 75 Weaver KN, Gregory M, Syal G. et al. Ustekinumab is effective for the treatment of Crohn's disease of the pouch in a multicenter cohort. Inflamm Bowel Dis 2019; 25 (04) 767-774
    CrossrefPubMedGoogle Scholar
  • 76 Kiran RP, Kirat HT, Rottoli M, Xhaja X, Remzi FH, Fazio VW. Permanent ostomy after ileoanal pouch failure: pouch in situ or pouch excision?. Dis Colon Rectum 2012; 55 (01) 4-9
    CrossrefPubMedGoogle Scholar
  • 77 Choi S. et al. Is ileoanal pouch excision a destination therapy for inflammatory bowel disease? Data from a quaternary pouch referral center. Gastroenterology 2021; 160 (06) S873-S874
    CrossrefPubMedGoogle Scholar
  • 78 Holubar SD, Neary P, Aiello A. et al. Ileal pouch revision vs excision: short-term (30-day) outcomes from the National Surgical Quality Improvement Program. Colorectal Dis 2019; 21 (02) 209-218
    CrossrefPubMedGoogle Scholar
  • 79 Raine T, Verstockt B, Kopylov U. et al. ECCO topical review: refractory inflammatory bowel disease. J Crohn's Colitis 2021; 15 (10) 1605-1620
    CrossrefPubMedGoogle Scholar
  • 80 Schwartzberg DM, Esen E, Remzi FH. Thoughtful ileostomy creation in patients undergoing redo IPAA. Dis Colon Rectum 2020; 63 (01) 117-120
    CrossrefPubMedGoogle Scholar
  • 81 Sapci I, Akeel N, DeLeon MF, Stocchi L, Hull T. What is the best surgical treatment of pouch-vaginal fistulas?. Dis Colon Rectum 2019; 62 (05) 595-599
    CrossrefPubMedGoogle Scholar
  • 82 Sivathondan PC, Bloemendaal A, Travis S, Mortensen N, George BD. Management of pouch-vaginal fistulas - experience from our institution. Colorectal Dis 2020; 22 (04) 439-444
    CrossrefPubMedGoogle Scholar
  • 83 Machin M, Younan HC, Slesser AAP, Mohsen Y. Systematic review on the management of ileoanal pouch-vaginal fistulas after restorative proctocolectomy in the treatment of ulcerative colitis. Colorectal Dis 2021; 23 (01) 34-51
    CrossrefPubMedGoogle Scholar
  • 84 Lavryk OA, Stocchi L, Shawki S. et al. Redo IPAA after a failed pouch in patients with Crohn's disease: is it worth trying?. Dis Colon Rectum 2020; 63 (06) 823-830
    CrossrefPubMedGoogle Scholar